CENTRAL NERVOUS SYSTEM LYMPHOMA
Clinical trials for CENTRAL NERVOUS SYSTEM LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CENTRAL NERVOUS SYSTEM LYMPHOMA trials appear
Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for brain lymphoma: study tests best treatment path
Disease control CompletedThis study looked at 227 adults with newly diagnosed primary CNS lymphoma, a rare brain cancer. It compared different chemotherapy combinations (with or without rituximab and thiotepa) followed by either whole-brain radiation or a stem cell transplant. The goal was to see which a…
Matched conditions: CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE2 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
Gene study may predict chemo side effects in lymphoma
Knowledge-focused CompletedThis study looked at how genetic differences affect the body's ability to clear high-dose methotrexate in patients with diffuse large B-cell lymphoma. Researchers analyzed DNA from 20 adult patients to find specific gene variations linked to slower drug removal. The goal is to be…
Matched conditions: CENTRAL NERVOUS SYSTEM LYMPHOMA
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC